ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of ...
Genialis, the therapeutic intelligence company, will present data at the European Society for Medical Oncology (ESMO) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results